San Jose, CA, United States of America

Sergei A Kazakov

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 2.5

ph-index = 3

Forward Citations = 26(Granted Patents)


Location History:

  • Los Gatos, CA (US) (2012 - 2015)
  • San Jose, CA (US) (2014 - 2024)

Company Filing History:


Years Active: 2012-2024

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Innovator Sergei A. Kazakov: Pioneering Advances in RNA Sequencing

Introduction

Sergei A. Kazakov, based in San Jose, CA, has made significant contributions to the field of biotechnology, particularly in RNA sequencing technologies. With an impressive portfolio of 11 patents, Kazakov is recognized for his innovative methods that advance our understanding of small RNAs and their applications in genomics.

Latest Patents

Among Kazakov's latest patents are groundbreaking methods related to library construction for polynucleotide sequencing. These methods focus on the detection of small RNAs within samples, providing essential techniques for preparing sequencing libraries. His work includes the development of methods, compositions, and kits that utilize target-specific oligonucleotides (TSOs). These innovations are crucial for attaching adapters and linkers to target RNAs and have various applications, including reducing the formation of secondary structures in target RNAs, which enhances detection and quantification in microarray and RT-qPCR applications.

Career Highlights

Sergei has had a dynamic career, having worked with notable companies like Somagenics, Inc. and Realseq Biosciences, Inc. His work in these organizations has significantly influenced the development of bioinformatics tools and sequencing techniques. Kazakov is recognized for his ability to bridge the gap between theoretical research and practical applications in the field of molecular biology.

Collaborations

Throughout his career, Kazakov has collaborated with esteemed colleagues, including Brian H. Johnston and Anne Dallas. These partnerships have fostered a collaborative environment that encourages the further development of innovative technologies and methodologies in RNA research.

Conclusion

Sergei A. Kazakov's contributions to the biotechnology sector through his extensive patent portfolio and collaborations with leading experts underscore his pivotal role in advancing RNA sequencing technologies. His dedication to improving methods for RNA analysis will undoubtedly leave a lasting impact on the field of genomics, paving the way for future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…